RxDoctor Payments DataLook up a doctor →

Donald Garcia

Psychiatry · Austin, TXNPI 1881925568

Payments from drug & device makers

$2,829,970in general payments, 2019–2025

Across 414 payments — averaging $6835.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$860K
  • Sage Therapeutics, LLC$725K
  • AbbVie$494K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$390K
  • Janssen Research & Development, LLC$188K
  • Biohaven Pharmaceuticals, Inc.$54K
  • plus $118K from 7 others
$4,053,505in research payments, 2019–2025

Across 276 payments — averaging $14,687 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$2.1M
  • AbbVie$896K
  • Sumitomo Pharma America, Inc.$540K
  • Jazz Pharmaceuticals Inc.$253K
  • Sage Therapeutics, LLC$214K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$33K
  • plus $22K from 1 others

General payments by program year

21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,829,970 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Other psychiatry in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →